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ABSTRACT:
Regulation of gene expression occurs at several levels, one being mRNA stability. Cis 
determinants, such as the poly(A) tail, 3’ and 5’ untranslated regions (UTRs), and coding region 
sequences along with trans-acting factors contribute significantly to mRNA stability. Our 
research focuses on the 3’ UTR of epidermal growth factor receptor (EGF-R) mRNA and its 
potential role as a stability determinant.
For this study, a chimeric construct was created containing the well-characterized rabbit 
13-globin gene with the EGF-R 3’ UTR replacing the 13-globin 3’ UTR (pBBUIII). A second 
plasmid (pcDNABBF) differing only in the 3’ UTR being from c-fos was made as a control. 
Both plasmids are controlled by the serum-induced c-fos promoter. Polysomes from serum- 
stimulated KB cells transfected with either plasmid will be added to an in vitro mRNA decay 
assay to determine the half-lives of each transcript. Presently this assay has not yet been 
performed in our laboratory, but we suspect the EGF-R 3’ UTR will stabilize the 13-globin 
transcript when compared to the effects of the c-fos 3’ UTR.
To study the involvement of nucleases specific to EGF-R mRNA decay, we utilized the 
in vitro mRNA decay assay using exogenous capped and uncapped EGF-R transcripts. Results 
suggest a role for the cap and polysomes from cells treated with EGF in increasing EGF-R 
mRNA stability in vitro. Unraveling the regulatory mechanisms involved in mRNA stability 
could provide practical ways to control gene expression.
Introduction
Gene expression is controlled at several levels. Recent studies examining the 
regulation of mRNA stability suggest that it plays a major role in regulating gene 
expression by directly affecting the abundance of mRNAs for each protein. The 
regulation of transcript turnover is especially important for short-lived mRNAs encoding 
for proteins that are necessary for rapid cellular responses to changes in the extracellular 
environment. Conversely, structural genes require their transcripts to be long-lived. 
Thus, different mRNAs (short-lived vs. long-lived) are regulated to have differential 
stabilities (Atwater et al., 1990). Also, differential stability of the same mRNA under 
different conditions can affect how a cell grows, differentiates, and responds to its 
environment (Ross, 1995).
The regulation of mRNA stability involves many factors. Removal of the poly(A) 
tail is often the first step in mRNA decay and is thought to serve a protective function. 
However, some transcripts are stable without a poly(A) tail. The coding region of some 
transcripts contain sequences that affect mRNA stability. Sequences within the 3* 
untranslated region (UTR) can directly or indirectly influence mRNA stability. The 3’ 
UTR of histone mRNA contains a critically located stem-loop at the end of its 3’ UTR 
that acts as a regulatory element throughout the cell cycle, perhaps by binding a stem- 
loop binding protein or histones themselves. Many 3’ UTRs contain AU-rich elements 
(AUREs) which typically have a pentamer motif (AUUUA) and a string of uracils (U). 
AUREs often confer instability, but their effects vary and seem to depend on the cell 
type, mRNA, and growth conditions (Ross, 1995). Removal of the c-fos 3’ UTR, which 
contains a destabilizing AURE, in serum-stimulated fibroblasts does not increase mRNA 
stability as expected. This may be because a second instability determinant within the 
coding region of c-fos mRNA provides an alternative degradative pathway (Shyu et al, 
1989). The c-fos AURE also accelerates poly(A) tail removal, possibly by U residues 
binding A’s from the poly(A) tract to create a RNase-sensitive double stranded RNA 
(Atwater et al., 1990). Several transcripts contain endonucleolytic cleavage sites within 
their 3’ UTRs (Ross, 1996). While the 5* UTR can affect mRNA half-life, it is uncertain 
whether they contain major stability determinants (Ross, 1995). The poly(A) tail, 3’ and 
5’ UTR, and coding region sequences, known as cis determinants, are illustrated in 
Figure 1. These sequences seem to play a major role in regulating mRNA stability, 
especially those within the 3* UTR.
A second class of factors that regulate mRNA stability and often interact with cis 
determinants are labile trans-acting factors. Quite often the addition of translation 
inhibitors stabilizes mRNA, which may be because such labile factors are no longer being 
synthesized. Several RNA-binding proteins exists which may be destabilizers, 
stabilizers, or simply have a regulatory role. For example, poly(A)-binding protein 
(PABP) binds the poly(A) tail and prevents the mRNA from degradation. Several 
proteins are known to bind AUREs, but their effects on mRNA stability are varied and 
seem to have regulatory rather than constitutive effects. Two observations suggest that 
AURE-binding proteins (AUBPs) influence mRNA stability: (1) AUBP abundance (or 
activity) increases or decreases as mRNA decay rates change and (2) AUBPs affect 
mRNA stability in cell-free extracts. Other proteins bind to one or a few mRNAs or to 
specific regions of the transcript, such as the 3* UTR or coding region. Although there is
2some evidence that mRNAses (exonucleolytic and endonucleolytic) exist, mammalian 
cells probably contain very few such enzymes (Ross, 1995). Ribosome-associated 
exoribonucleases have been identified but are not yet classified as authentic mRNAses. 
mRNA decay pathways involving nucleolytic cleavage in mammalian cells are illustrated 
in Figure 2. Hormones, growth factors, cytokines, calcium and iron can also regulate 
mRNA stability (Ross, 1996).
Epidermal growth factor (EGF) stimulates cellular proliferation through DNA, 
RNA and protein synthesis by binding to its receptor (EGF-R) and activating a 
intracellular tyrosine kinase. EGF-R is a proto-oncogene related to the v-erb-B oncogene 
product of avian erythroblastosis virus (Kesaven et al., 1990). Several human carcinomas 
express high levels of EGF-R and have amplified EGF-R genes (Clark et al, 1986). 
Hyperexpression of EGF-R could be due to any of the following mechanisms: (a) gene 
amplification; (b) increased transcription rate; (c) increased mRNA stability; (d) 
enhanced translation rate; (e) enhanced stability o f receptor protein (Kesaven et al, 1990). 
Our research focuses on the regulation of EGF-R mRNA stability as a mechanism for 
controlling receptor expression and specifically attempts to elucidate the role of the 3’ 
UTR.
Several studies propose mechanisms by which EGF-R mRNA stability is 
regulated. In KB cells, EGF stabilizes EGF-R mRNA in vivo and most likely is due to a 
post-transcriptional event (Jinno, 1988). Previously, our lab found that EGF-R mRNA 
was stabilized two-fold in vitro when treated with EGF-treated polysomes versus 
controls. Additional sucrose density gradient studies showed that EGF appears to induce 
polysomal loading on EGF-R mRNA, which results in increased stability (unpublished). 
These findings support other studies which also suggest that EGF stabilizes its receptor 
mRNA, but a clear mechanism remains to be discovered.
Studies involving other cell lines indicate a role for the 3’ UTR of EGF-R mRNA 
in regulating transcript stability. A431 cells produce a native 5.6 kb transcript and a 
truncated 2.6 kb version that is missing the 3’ UTR and part of the coding region. The 
stability of the truncated transcript is approximately two-fold higher in vivo than the 5.6 
kb mRNA when treated with EGF and increases ten-fold when EGF-treatment is 
combined with the translation inhibitor cyclohexamide. Combined, these results suggest 
that a ligand (EGF) and labile proteins are involved in the control of EGF-R mRNA 
synthesis and stability. These findings also imply that structural features of the 3* UTR 
function to control EGF-R mRNA stability (Kesaven et al, 1990). A similar phenomenon 
occurs in AH66 rat hepatoma cells. A truncated version of EGF-R mRNA is 4 times 
more stable than the full-length transcript in vivo. The reverse transcription polymerase 
chain reaction (RT-PCR) revealed that the full-length transcript contains an ATTTA 
cDNA sequence in its 3’ end that is absent in the truncated transcript. This cDNA 
sequence may correspond to a destabilizing AURE in EGF-R mRNA that confers 
instability on the full-length transcript (Satoh et al., 1997).
The purpose of my research is to determine whether the 3* UTR of EGF-R mRNA 
plays a role in regulating stability of the transcript and if so, how? A chimeric transcript 
containing the coding region of rabbit 6-globin as a reporter gene was used to elucidate 
the effects of the 3* UTR of EGF-R mRNA. Experiments with a second chimeric 
transcript containing the coding region of rabbit 6-globin and the c-fos 3’ UTR replacing 
the 6-globin 3’ UTR have been done previously. It was shown that the c-fos 3’ UTR
3reduced the half-life of the normally stable B-globin message so that it acted much like 
the c-fos transcript (Shyu et al., 1991). We utilized this construct as a control since its in 
vivo half-life is known. To measure the effects of the EGF-R 3* UTR, stabily transfected 
cells will be utilized for an in vitro and (and possibly in vivo) mRNA decay assay. If B- 
globin stability is affected by the EGF-R 3* UTR, it would be of interest to create 
truncated version of the experimental plasmid to determine the location of the sequence 
determinants.
An in vitro mRNA decay assay using a synthetically generated trancript was 
performed to further examine the possible role of nucleases in regulating EGF-R mRNA 
stability. Decay of capped and uncapped radiolabeled EGF-R transcripts were measured 
in the presence of polysomes from cells treated or untreated with EGF. This experiment 




Plasmid pBBUIII encodes a chimeric message consisting of the rabbit P-globin 5’ 
UTR, rabbit p-globin coding region, and EGFR 3’ UTR. Plasmid pcDNABBF differs 
only in having the c-fos 3’UTR in place of EGFR 3* UTR. Transcription of both 
plasmids is controlled by the serum-stimulated c-fos promoter, which shuts down after 30 
minutes.
The starting plasmid, pcDNAEI (In Vitrogen), contains a CMV promoter, 
polycloning site, and neomycin resistance gene (Figure 3). The Bgin site of pcDNAm 
was changed to SacII by cutting with Bgin, blunt ending overhangs, ligating a SacE 
linker, and religating the plasmid (pcDNASE). The CMV promoter (638 bp) was 
removed with SacE/EcoRV and replaced with the 2122 bp SacE/EcoRV fragment from 
pBBF (Shyu et al, 1989), which contains a c-fos promoter, the rabbit P-globin 5’ UTR 
and coding region, and the c-fos 3* UTR (pcDNABBF). A PCR amplified fragment of 
EGFR (3761-5532 bp) from pUTR was cloned into the pGEM T-easy (Promega) vector. 
This insert contains the 3’ UTR and a small portion of the coding region. The 3* end of 
the insert was changed to Bgin (pUTRBII). Lastly, pcDNABBF was cut with BglE/XhoI 
to remove the c-fos 3’ UTR (550 bp) and replaced with the EGFR 3’ UTR (1787 bp 
BglE/XhoI fragment of pUTRBII) to construct pBBUm (7867 bp). Figure 4 illustrates 
the overall cloning procedure and Figure 5 depicts the expected transcripts from 
pcDNABBF and pBBUffl.
Transfections
KB cells were transfected transiently or stabily with pcDNABBF or pBBUin 
using the standard calcium phosphate transfection protocol as described in Molecular 
Cloning: A Lab Manual (Cold Spring Harbor Laboratory Press, 1989). KB cells were 
plated at 5 x 105 cells/10 cm dish and allowed to reach 90% confluency. To test for 
transcription efficiency, plasmids were co-transfected with pGreen Lantern-1 (Life 
Technologies), which generates a fluorescent protein detectable under the fluorescent
4microscope (Figure 6). The optimal amount of plasmid DNA was determined to be 20
Cells from transient transfections were harvested 48 hours after tranfection and 
RNA was isolated using Caltrimox-14 cationic surfactant (Dahle and Macfarlane 1993). 
Control cells received no plasmid but were serum stimulated for 30 minutes. Transfected 
cells representing a steady state level of transcription were not serum stimulated but 
harvested after the 48 hour transfection period. A second group of transfected cells were 
serum stimulated for 30 minutes to generate a high transient level of expression. Samples 
were stored at -80°C.
Stable transfections received G418 5% medium (which contains neomycin) 48 
hours after tranfection and subsequently changed every 3 days. After 3-4 weeks, cell 
colonies were isolated and grown in a 24 multi-well dish until confluent. Cells were 
transferred to 10 cm plates and grown to confluency. Cells were then serum stimulated 
for 30 minutes, harvested, and RNA isolated. Samples were stored at -80°C.
Detecting Plasmid Expression
Transient transfections were utilized to detect the presence of plasmid transcripts 
pcDNABBF and pBBUin. RNA samples were reconstituted in the appropriate volume 
of DEPC water and absorbance at 260 nm was measured. Eight pg of RNA for each 
sample was precipitated at -20°C for the RNase protection assay.
A 640 bp BamHI/EcoRI DNA fragment of rabbit p-globin from pcDNABBF was 
cloned into a pGEM7 vector (Promega) and an anti-sense RNA was transcribed from the 
T7 promoter in the presence of 32P-UTP in vitro according to MAXIScript™. A probe 
for GAPDH (300 bp) was also constructed to detect expression of the control GAPDH 
transcript. To make the 6-globin probe, the pGEM7 plasmid containing the rabbit 6- 
globin fragment was linearized with BamHI. The DNA template was subjected to the 
transcription reaction for 30 minutes at 37°C with the necessary reagents to generate the 
radiolabeled anti-sense RNA probe. The DNA template was removed by adding DNase 1 
for 15 minutes at 37°C. Each sample was hybridized overnight at 42°C with 3xl05 cpm 
of the 6-globin probe and 2xl05 cpm of the GAPDH probe.
The next day, samples of total RNA were subjected to the RNase protection 
assay. Each sample received 400 pi of RNase cocktail for 30 minutes. Proteinase K in 
SDS was then added for 30 minutes to destroy RNase activity. After phenol-chloroform 
extraction, 400 pi of isopropanol and 4 pi tRNA carrier were added to the supernatant 
and incubated at -80°C for 15 minutes. Samples were centrifuged at 15,000xg for 10 
minutes and the supernatant removed. Formamide loading buffer was added to each 
tube. Samples were heated for 2 minutes at 100°C and loaded onto a 2M urea/7% 
polyacrylamide gel. Gels were exposed to X-ray film and analyzed.
In Vitro mRNA Decay Assay Utilizing a Exogeneous Transcript
Two P-UTP labeled EGF-R sense transcripts were synthesized in vitro using 
MAXIScript™ kits and protocols (Ambion Inc, Austin, Texas), one with a 5’ methylated 
cap (m7GpppG) and one without a cap. Both transcripts were alloquated so each tube 
contained 5x104 cpm. Controls received tRNA in place of polysomes. Experimental
5samples received 4 pi (0.4 O.D.260) of polysomes from control or EGF-treated cells. Also 
included in each tube was a buffering system, ATP-generating system, placental 
ribonuclease inhibitor and magnesium ion. Samples were incubated for 0, 1, 3, 6, 9, and 
12 hours and RNA was isolated. Formamide loading buffer was added to each sample. 
Samples were denatured for two minutes at 100°C and loaded onto a 2M urea/7% 
polyacrylamide gel. Gels were exposed to X-ray film and analyzed.
Results
Transfections
Transient and stable transfections were performed with KB cells using the 
calcium phosphate precipitate protocol. Transiently transfected cells were co-transfected 
with pGreen Lantern-1, which generates a protein that fluoresces under the fluorescent 
microscope. The amount of fluorescent protein was examined 48 hours after transfection. 
Both cells lines showed minimal amounts of protein compared to previous observations 
with other plasmids co-transfected with pGreen Lantern-1.
Stabily transfected cells are currently being cultured for future experiments. Of 
interest is the observation that pBBUin transfected cells tend to grow more slowly while 
pcDNABBF cells reach confluency more rapidly. Also, pBBUin cells are more 
fibroblastic in morphology. These observations indicate that pBBUin, specifically the 
EGF-R 3’ UTR component, may have some effect on KB cell morphology through an 
unknown mechanism.
Plasmid Expression
Expression of pBBUin and pcDNABBF from transiently transfected cells was 
detected during co-transfection experiments with pGreen Lantern-1 but was minimal. 
Total RNA from these cells was subjected to the highly sensitive RNase protection assay. 
The 640 nt radiolabled antisense probe for rabbit B-globin ensures specificity for both 
transcripts. Transfection efficiency was too low to detect pcDNABBF or pBBUin 
expression for transiently transfected cells. This assay should be repeated using stabily 
transfected cells which are currently being cultured.
Once plasmid expression has been confirmed, an in vitro and in vivo mRNA 
decay assay will be performed. Polysomes from serum-stimulated cells will be added to 
the assay and transcripts decay for 0, 1, 3, 6, 9, and 12 hours. The RNA will be isolated 
from the decay assay samples and B-globin transcript levels measured by the RNase 
protection assay using the 640 nt probe previously mentioned. We suspect that 
transcripts from pBBUin will be more stable than those from pcDNABBF (in vitro half- 
life = 30 minutes) but not as stable as the B-globin transcript regulated by the c-fos 
promoter (in vitro half-life = 24 hours) (Shyu et al., 1989).
In Vitro Decay Assay Utilizing an Exogenous Transcript
To examine the effects of differentially treated polysomes and the 5’ methylated 
cap on the decay of artificially labeled EGF-R transcripts, we performed an in vitro
6mRNA decay assay. As shown in Figure 7, the uncapped EGF-R message decays more 
rapidly when treated with polysomes from cells treated with or without EGF. 
Conversely, the capped EGF-R mRNA decays more slowly with polysomes from cells 
treated with or without EGF when compared to controls. More specifically, the capped 
EGF-R transcript decays more slowly when exposed to polysomes from EGF-treated 
cells. Thus, the 5’ methylated cap may enhance stability of the transcript and act 
synergistically with EGF in the native in vivo situation.
Discussion
The present study attempts to examine the effects of the 3 s UTR of EGF-R 
mRNA on transcript stability. To do this, a chimeric construct containing the well- 
characterized B-globin gene and EGF-R 3’ UTR was created (pBBUm). As a control, a 
second chimeric plasmid was made in which the EGF-R 3’ UTR was replaced by the 
destabilizing c-fos 3’ UTR (pcDNABBF). This second plasmid has been previously 
utilized and its transcript has a known in vitro half-life of 30 minutes (Shyu et al, 1991). 
Many investigators have used chimeric mRNAs to identify sequences that are involved in 
determining mRNA stability. It must be mentioned, however, that results from such 
studies should be interpreted cautiously. Manipulating mRNA structure may affect 
stability so that it is difficult to determine if the segment of interest is acting as a stability 
determinant or if the results are due to creating the chimeric transcript. For example, a 
truncated mRNA may be more stable than the full-length transcript, not because it lost a 
stability determinant but because it is translated more efficiently (Ross, 1995). Since our 
goal is to measure mRNA half-life in vitro, this variable is of no concern.
Both plasmids are regulated by the serum-induced c-fos promoter. In the 
presence of serum the promoter is induced for 30 minutes, after which it shuts down. 
This system has two distinct advantages: (1) mRNA synthesis is controlled without the 
need for transcription inhibitors, which stop all transcription and perhaps the subsequent 
translation of labile factors involved in mRNA decay; (2) the promoter is tightly 
regulated and there is little chance for undesired transcription of c-fos promoter- 
controlled genes for at least 10 hours; this permits the possibility of measuring long half- 
lives (Ross, 1995). Thus, the c-fos promoter is excellent for experiments using in vivo 
methodologies.
Another advantageous method to be applied in our study is the in vitro mRNA 
decay assay. First, decay intermediates that are difficult to measure using in vivo systems 
can often be observed in cell-free systems. Second, the reaction conditions are easily 
controlled (Ross, 1994). Also, decay rates from cell-free extracts are comparable to those 
measured in vivo. The in vitro assay has been well characterized for KB cells in previous 
experiments in which endogenous EGF-R mRNA stability was measured in 
polyribosomes from cells treated with and without EGF (unpublished).
We have yet to test for expression of our plasmids in stabily transfected KB cells. 
Due to low transfection efficiency, plasmid expression in transiently transfected cells was 
too poor to use these cells for further experiments. The calcium phosphate transfection 
protocol is quite inefficient with only 20% of a population of cultured cells (depending on 
the cell type) transfected at one time (Cold Spring Harbor Laboratory Press, 1989). It is 
more likely that the stabily transfected cell lines will provide adequate expression and
7thus extracted polyribosomes from these cells could be subjected to the in vitro mRNA 
decay assay. More efficient transfection methods should be investigated. Lipofection 
seems to be a promising technique as it is simple and efficient. The DNA is encapsulated 
within a liposome, followed by fusion of the liposomes with the cell membrane. If the 
stabily tranfected cell lines do not provide adequate expression of the plasmids, the 
liposome technique will most likely be investigated.
One interesting observation noted throughout the culturing of stabily transfected 
cells was the morphological difference seen in cells receiving pBBUm. Most often these 
cells took on a fibroblastic morphology and tended to grow to confluency more slowly 
than cell receiving pcDNABBF. Perhaps the additional EGF-R 3* UTR of pBBUm 
bound labile factors that normally bind to the 3’ UTR of the endogenous transcript and 
effected its stability. Down-regulation of EGF-R would cause the cells to act less like 
cancer cells and be more fibroblastic in cell culture. To test this could measure not only 
the amount of fi-globin mRNA expressed by pBBUm but also the amount of endogenous 
EGF-R mRNA and compare it to the levels found in un-transfected KB cells.
Although our laboratory is unable at this time to suggest a role for the 3’ UTR of 
EGF-R mRNA in regulating transcript stability, findings from previous studies provide 
numerous ideas on the topic. Jinno et al. reports a 2.5-fold increase in EGF-R mRNA 
stability when KB cells are pre-treated with EGF and half-lives are measured in vivo 
(1988). It appears that EGF-R mRNA levels are increased by stabilizing the transcript 
versus increasing the transcription rate. The investigators recognize the existence of 
stability-determining sequences within the 3* UTR and speculate that EGF may somehow 
alter the 3’ end of EGF-R mRNA.
Altering the mRNA structure seems to affect mRNA stability as illustrated by two 
similar studies where the 3’ end of EGF-R mRNA is missing. A 2.6 kb truncated EGF-R 
mRNA (at the 3’ end) produced by A431 cells is more stable compared to the 5.6 kb full- 
length transcript when measured in vivo. The most significant change was a 10-fold 
increase in stability of the 2.6 kb message when cells were pre-treated with EGF and 
cyclohexamide. This suggests a synergism between the labile dependent pathway and the 
EGF directed pathway of EGF-R mRNA degradation. Several other mRNAs that contain 
AUREs in their 3’ UTRs are stabilized by cyclohexamide. These sequences may serve as 
labile nuclease recognition sites. Since the EGF-R transcripts (2.6 kb and 5.6 kb) were 
only modestly stabilized by cyclohexamide, multiple pathways may be involved. Thus, 
the investigators suggest roles for labile proteins, unknown EGF-inducible signals, and 
mRNA structure in the regulation of EGF-R mRNA degradation (Kesaven et al, 1990).
A similar phenomenon is observed in AH66 cells, where an EGF-R mRNA 
truncated at its 3* end is 4-fold more stable than the full-length transcript. A cDNA 
sequence corresponding to an AURE was identified within the 3’ UTR of the EGF-R 
message and may be a destabilizing element since in its absence (in the truncated mRNA) 
the transcript is stable. Satoh et al. also believe there is a connection between mRNA 
degradation and translation. Polyribosome-bound ribonucleases and their interaction 
with mRNAs are suggested. Perhaps the full-length transcript preferentially binds to 
polyribosomes, is translated and subsequently degraded by the nucleases whereas the 
truncated mRNA rarely forms polyribosomes and remains stable (1997). This relates 
back to the importance of mRNA structure and its effects on mRNA stability.
8The results from the in vitro mRNA decay assay using an exogeneous EGF-R 
transcript suggest a role for the 5”methylated cap and EGF. Most mRNAs are less stable 
without the 5’ cap in cell-free mRNA decay reactions (Ross, 1995). Indeed, our results 
demonstrate that the capped EGF-R transcript is more stable than the uncapped. What is 
interesting is that the only in the capped transcripts did the polysome type further affect 
stability. Capped transcripts treated with EGF-treated polysomes were more stable than 
those receiving control polysomes. This was not seen with the uncapped EGF-R 
mRNAs. The 5* cap may enhance transcript stability and act synergistically with EGF in 
KB cells. Perhaps the cap functions primarily to stabilize the entire transcript and 
subsequently allows EGF “time” to enhance stability by inactivating certain 
polyribosome-bound nucleases or causing polysomal loading onto the transcript (EGF is 
known to elicit the latter event in vitro).
mRNA stability plays a major role in gene expression in mammalian cells and 
many of the mechanism or factors controlling the regulation of mRNA decay are 
unknown. Not only will it be important to determine the various cis determinants 
affecting mRNA stability for individual transcripts but also the /ra«s-acting factors 
involved. There are many practical reasons for studying mRNA stability. Increased 
mRNA stability is one mechanism of hyperexpression of genes and their protein 
products, which may be important in oncogenesis (Kesaven et al., 1990). Several human 
carcinomas show high levels of EGF-R and amplified or altered EGF-R transcripts (Clark 
et al., 1986). The v-erb-B oncogene of avian erythroblastosis virus encodes a truncated 
version of EGF-R and it has been proposed that it transforms by acting as a constitutively 
activated EGF receptor (Schlessinger, 1998), The EGF-R 3’ UTR may contain an AURE 
and AURE-directed mRNA decay is linked to transformation and oncogenesis (Chen and 
Shyu, 1995). If certain classes of mRNAs are regulated by common factors (such as 
AUBPs), it would be advantageous to design compounds that could target such factors 
and block or enhance their activity (Ross, 1995). Much work also needs to be done 
considering the methods and techniques for studying mRNA decay. Animal studies 
would bring about novel and important insights as to how mRNA stability influences 
biological processes (Ross, 1995). Currently no reliable techniques exist for measuring 
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Figure 1. Some mRNA Stability Determinants. Open arrows show locations o f  
the determinants. Solid arrows indicate determinants that are cleavage sites in cells 
and, in some cases, in vitro. AU  represents AU-rich elements. Rectangles and 
lines denote coding regions and untranslated regions, respectively.
Figure 2. mRNA Decay Pathways Involving N ucleolvtic Cleavage. Rectangles 
and lines denote coding regions and untranslated regions, respectively, (a) the 
poly(A ) tail is shorted by nucleases, but it is unclear whether this occurs exo- or 
endonucleolytically (b) early degradation o f histone mRNA occurs via a 3 ’ to 5 ’ 
exonuclease (c) insulin-like growth factor II is cleaved endonucleolytically within 
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Comments for pcDNA3 
5446 nucleotides
CMV promotor: bases 209-863
T7 promoter: bases 864-882
Polylinker bases 889-994
Sp6 promoter bases 999-1016
BGH poly A: bases 1018-1249
SV40 promoter bases 1790-2115
SV40 origin of replication: bases 1984-2069
NeoHORh: bases 2151-2932
SV40 poly A: bases 2933-3128
p(JCl9 backbone: bases 3272-5446
AmpRORF: bases 4450-5310
Figure 3. pcDNAIII (In Vitrogen). W e utilized this expression vector for both 
chimeric constructs pBBUIII and pcDNABBF (see Figure 4). The CMV promoter 
w as removed and replaced with the serum-induced c-fos promoter. The neomycin 
gene was useful for selecting stabily transfected cells that received either plasmid 
successfully.
Figure 4. The construction of chimeric plasmids pcDNABBF and pBBUIII. The 
CMV promoter of pcDNASII was removed and replaced with a 2122 bp insert 
containing the c-fos promoter, rabbit B-globin 5’ UTR, rabbit B-globin coding 
region, and c-fos 3’ UTR. The 550 bp c-fos 3’ UTR was then removed. The EGF- 
R 3’ UTR from pUTRBII was removed and inserted into pcDNABBF (with the c- 
fos 3’ UTR removed) to created pBBUIII, which contains the c-fos promoter, 
rabbit B-globin 5’ UTR and coding region, and EGF-R 3’ UTR (plus some of the 
coding region).
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Figure 6. pGreen Lantem-1 (Life Technologies).
Plasmid p G reen Lantern,m-1
Plasmid p G reen Lantern- I is suitable as a reporter plasmid for transfection of 
eukaryotic cells. The plasmid contains a mutated form of the gene for Green 
Fluorescent Protein (GFP) from Aequorea victoria jellyfish (l,2 ). GFP requires no 
substrates for visualization, and is easily monitored with FITC filter sets in living 
as well as fixed cells, and in whole animals. Cells transfected with p G reen 
Lantern- l can be viewed by fluorescent microscopy, sorted by FACS, or measured 
by fluorescent plate readers.
The G reen L antern- l GFP gene has several mutations that improve fluorescence 
over 40-fold compared to wild-type GFP, for enhanced detection: A Ser65-»Thr 
mutation (3) that shifts the major excitation peak to 490 nm, and over 80 
“humanized” mutations (4) to create a pattern of codon usage that reflects the 
abundance of tRNAs in a mammalian population. These mutations result in 
detection in as little as 5 h after transfection.
Plasmid p G reen Lantern- l contains the cytomegalovirus (CMV) immediate early 
promoter for high expression of GFP in many mammalian cells. An SV40 
polyadenylation signal downstream of the GFP gene directs proper processing of 
the mRNA in eukaryotic cells. The G reen Lantern- l GFP gene is flanked by Not I 
sites for easy excision and subsequent subcloning into other vectors.
Performance and quality testing: Purity and selected restriction sites are verified 
by agarose gel analysis. Expression of GFP is confirmed by transfection of 
BHK-21 cells using LipofectAMINE'“ Reagent and examination by fluorescence 
microscopy using FITC filters.
Concentration in storage buffer: 500 pg/ml in 10 mM Tris-HCI (pH 7.4), 5 mM 
NaCl, O.l mM EDTA.
Recommended storage condition: 4°C.
Reference(s):
1. Praslicr, D.C., Eckcnrodc. V.K., Ward. W.W., Pendcrgast, F.G., and Cormier, M.J. (1992) Gene III,  
229.
2. Chalfic, M„ Tu, Y„ Euskirchen, G.. Ward, W.W., and Prashcr, D.C. (1994) Science 263, 802.
3. Heim, R., Cubitl. A.B., and Tsicn, R.Y. (1995) Nature 373, 663.
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Figure 7. Results of the In Vitro mRNA Decay Assay Using an Exogenous Transcript. EGF-R 
mRNA decay is shown for capped and uncapped exogenous transcripts. The uncapped message 
decays more rapidly when exposed to polysomes from cells treated or untreated with EGF. 
These results suggest involvement of polyribosome-associated nucleases in EGF-R mRNA decay 
in vitro. Capped transcripts behave similarly but decay more slowly when exposed to polysomes 
relative to uncapped transcripts. The largest increase in stability is seen with the capped 
transcript exposed to polysomes from EGF-treated cells. These results suggest a role for the 5’ 
cap and EGF in regulating EGF-R mRNA stability in vitro.
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